5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Biomol Biomed. 2018;18(2):170-177. doi:10.17305/bjbms.2017.2258